IBDEI2U2 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,47550,0)
 ;;=C84.97^^209^2346^310
 ;;^UTILITY(U,$J,358.3,47550,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47550,1,3,0)
 ;;=3^Mature T/NK-Cell Lymphomas Unspec,Spleen
 ;;^UTILITY(U,$J,358.3,47550,1,4,0)
 ;;=4^C84.97
 ;;^UTILITY(U,$J,358.3,47550,2)
 ;;=^5001678
 ;;^UTILITY(U,$J,358.3,47551,0)
 ;;=C84.98^^209^2346^309
 ;;^UTILITY(U,$J,358.3,47551,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47551,1,3,0)
 ;;=3^Mature T/NK-Cell Lymphomas Unspec,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,47551,1,4,0)
 ;;=4^C84.98
 ;;^UTILITY(U,$J,358.3,47551,2)
 ;;=^5001679
 ;;^UTILITY(U,$J,358.3,47552,0)
 ;;=C84.99^^209^2346^303
 ;;^UTILITY(U,$J,358.3,47552,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47552,1,3,0)
 ;;=3^Mature T/NK-Cell Lymphomas Unspec,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,47552,1,4,0)
 ;;=4^C84.99
 ;;^UTILITY(U,$J,358.3,47552,2)
 ;;=^5001680
 ;;^UTILITY(U,$J,358.3,47553,0)
 ;;=C85.10^^209^2346^67
 ;;^UTILITY(U,$J,358.3,47553,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47553,1,3,0)
 ;;=3^B-Cell Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,47553,1,4,0)
 ;;=4^C85.10
 ;;^UTILITY(U,$J,358.3,47553,2)
 ;;=^5001701
 ;;^UTILITY(U,$J,358.3,47554,0)
 ;;=C85.11^^209^2346^60
 ;;^UTILITY(U,$J,358.3,47554,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47554,1,3,0)
 ;;=3^B-Cell Lymphoma,Head/Face/Neck Nodes
 ;;^UTILITY(U,$J,358.3,47554,1,4,0)
 ;;=4^C85.11
 ;;^UTILITY(U,$J,358.3,47554,2)
 ;;=^5001702
 ;;^UTILITY(U,$J,358.3,47555,0)
 ;;=C85.12^^209^2346^64
 ;;^UTILITY(U,$J,358.3,47555,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47555,1,3,0)
 ;;=3^B-Cell Lymphoma,Intrathoracic Nodes
 ;;^UTILITY(U,$J,358.3,47555,1,4,0)
 ;;=4^C85.12
 ;;^UTILITY(U,$J,358.3,47555,2)
 ;;=^5001703
 ;;^UTILITY(U,$J,358.3,47556,0)
 ;;=C85.13^^209^2346^62
 ;;^UTILITY(U,$J,358.3,47556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47556,1,3,0)
 ;;=3^B-Cell Lymphoma,Intra-Abdominal Nodes
 ;;^UTILITY(U,$J,358.3,47556,1,4,0)
 ;;=4^C85.13
 ;;^UTILITY(U,$J,358.3,47556,2)
 ;;=^5001704
 ;;^UTILITY(U,$J,358.3,47557,0)
 ;;=C85.14^^209^2346^58
 ;;^UTILITY(U,$J,358.3,47557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47557,1,3,0)
 ;;=3^B-Cell Lymphoma,Axilla/Upper Limb Nodes
 ;;^UTILITY(U,$J,358.3,47557,1,4,0)
 ;;=4^C85.14
 ;;^UTILITY(U,$J,358.3,47557,2)
 ;;=^5001705
 ;;^UTILITY(U,$J,358.3,47558,0)
 ;;=C85.15^^209^2346^61
 ;;^UTILITY(U,$J,358.3,47558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47558,1,3,0)
 ;;=3^B-Cell Lymphoma,Ing Region/Lower Limb Node
 ;;^UTILITY(U,$J,358.3,47558,1,4,0)
 ;;=4^C85.15
 ;;^UTILITY(U,$J,358.3,47558,2)
 ;;=^5001706
 ;;^UTILITY(U,$J,358.3,47559,0)
 ;;=C85.16^^209^2346^63
 ;;^UTILITY(U,$J,358.3,47559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47559,1,3,0)
 ;;=3^B-Cell Lymphoma,Intrapelvic Node
 ;;^UTILITY(U,$J,358.3,47559,1,4,0)
 ;;=4^C85.16
 ;;^UTILITY(U,$J,358.3,47559,2)
 ;;=^5001707
 ;;^UTILITY(U,$J,358.3,47560,0)
 ;;=C85.17^^209^2346^66
 ;;^UTILITY(U,$J,358.3,47560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47560,1,3,0)
 ;;=3^B-Cell Lymphoma,Spleen
 ;;^UTILITY(U,$J,358.3,47560,1,4,0)
 ;;=4^C85.17
 ;;^UTILITY(U,$J,358.3,47560,2)
 ;;=^5001708
 ;;^UTILITY(U,$J,358.3,47561,0)
 ;;=C85.18^^209^2346^65
 ;;^UTILITY(U,$J,358.3,47561,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47561,1,3,0)
 ;;=3^B-Cell Lymphoma,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,47561,1,4,0)
 ;;=4^C85.18
 ;;^UTILITY(U,$J,358.3,47561,2)
 ;;=^5001709
 ;;^UTILITY(U,$J,358.3,47562,0)
 ;;=C85.19^^209^2346^59
 ;;^UTILITY(U,$J,358.3,47562,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47562,1,3,0)
 ;;=3^B-Cell Lymphoma,Extranodal/Solid Organ Sites
